These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3539086)

  • 21. In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides.
    Ton MN; Chang C; Carpentier YA; Deckelbaum RJ
    Clin Nutr; 2005 Aug; 24(4):492-501. PubMed ID: 16054521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parenteral lipid emulsions in paediatrics.
    Krohn K; Koletzko B
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):319-23. PubMed ID: 16607135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of muscle amino acid release by infusion of a triglyceride emulsion].
    Rett K; Wicklmayr M; Baldermann H; Schwiegelshohn B; Dietze G; Mehnert H
    Infusionstherapie; 1988 Apr; 15(2):78-82. PubMed ID: 3397192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic reflection of an infusion of fructose, sorbitol and xylitol in healthy subjects and the effect of tolbutamide and butylbiguanide.
    Brodan V; Válek J; Slabochová Z; Kuhn E; Brodanová M
    Rev Czech Med; 1973; 19(2):89-110. PubMed ID: 4710149
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucose and fat utilization during intravenous administration of glucose and lipid emulsion in non-insulin-dependent diabetic patients.
    Pelikánová T; Krausová Z; Kohout M; Válek J; Basĕ J
    Nutrition; 1993; 9(1):18-22. PubMed ID: 8467106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid changes in liver lipid composition and pancreatic islet K+ handling and secretory behaviour provoked by the intravenous administration of a medium-chain triglyceride: fish oil emulsion to long-chain polyunsaturated omega3 fatty acid-depleted rats.
    Louchami K; Zhang Y; Oguzhan B; Delporte C; Portois L; Carpentier YA; Genten F; Danguy A; Malaisse WJ; Sener A
    Int J Mol Med; 2006 Dec; 18(6):1047-55. PubMed ID: 17089007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of liver function by metabolic parameters].
    Kleinberger G
    Klin Anasthesiol Intensivther; 1987; 34():46-58. PubMed ID: 3682706
    [No Abstract]   [Full Text] [Related]  

  • 28. [The oxidation rate of various, parenterally administered 13C-marked triglycerides in polytraumatized patients].
    Adolph M; Eckart J; Metges C; Neeser G; Wolfram G
    Beitr Infusionsther; 1990; 25():439-55. PubMed ID: 1690066
    [No Abstract]   [Full Text] [Related]  

  • 29. The plasma clearance of synthetic emulsions of triglycerides containing long chain fatty acids and medium chain fatty acids.
    Guisard D; Gonand JP; Laurent J; Debry G
    Rev Eur Etud Clin Biol; 1970; 15(6):674-8. PubMed ID: 5470690
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolic effects of a medium-chain triglyceride emulsion injected intravenously in man.
    Guisard D; Debry G
    Horm Metab Res; 1972 Nov; 4(6):509. PubMed ID: 4347824
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of particle size and emulsifier on pharmacokinetic values of a parenterally administered fat emulsion].
    Weidler B; Peil J; von Bormann B; Lohmann E; Elmadfa I; Sommermeyer K; Schwanen N
    Infusionsther Klin Ernahr; 1987 Apr; 14(2):78-88. PubMed ID: 3610312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hypertriglyceridemic clamp technique. Studies using long-chain and structured triglyceride emulsions in healthy subjects.
    Nordenström J; Thörne A; Aberg W; Carneheim C; Olivecrona T
    Metabolism; 2006 Nov; 55(11):1443-50. PubMed ID: 17046545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma clearance of MCT/LCT and LCT emulsions in diabetic patients].
    Rett K; Wicklmayr M; Dietze G; Mehnert H
    Beitr Infusionther Klin Ernahr; 1988; 20():179-88. PubMed ID: 3377746
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clearance of lipids from the blood of subjects with alcoholic liver cirrhosis with ascites].
    Guisard D; Bigard MA; Debry G
    Nutr Metab; 1972; 14(4):193-202. PubMed ID: 4650263
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relative and absolute contraindications of parenteral lipid administration].
    Kleinberger G
    Beitr Infusionther Klin Ernahr; 1986; 13():154-77. PubMed ID: 3790050
    [No Abstract]   [Full Text] [Related]  

  • 36. An update on parenteral lipids and immune function: only smoke, or is there any fire?
    Wanten G
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):79-83. PubMed ID: 16477169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oxidative utilization of 13C-labeled medium-chain triglycerides in respiratory intensive care patients].
    Adolph M; Eckart J; Metges C; Neeser G; Wolfram G
    Beitr Infusionther Klin Ernahr; 1988; 20():126-44. PubMed ID: 3132140
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on metabolism of fat emulsion in endotoxemic dogs].
    Mori H
    Nihon Geka Gakkai Zasshi; 1983 Dec; 84(12):1213-9. PubMed ID: 6674778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exocrine pancreas secretion after a dose of medium- and long-chain triglycerides].
    Niederau C
    Beitr Infusionther Klin Ernahr; 1988; 20():55-68. PubMed ID: 2454098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.